Background illustration for clinical trials search

Paid Clinical Trials Detroit

Discover 1,727 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

for
Familial Adenomatous Polyposis (FAP)
Location: Ann Arbor MI, Cleveland OH, Columbus OH, Pittsburgh PA,
Sponsor: Rapamycin Holdings Inc.

Sex: All

Age: 18+

Code: NCT06950385

Phase 3, Recruiting

Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer

for
Castration-Resistant Prostate Carcinoma,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: Male

Age: 18+

Code: NCT06616155

Phase 1, Phase 2, Recruiting

Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas

for
Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT05956041

Phase 2, Recruiting

CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation

for
Atrial Fibrillation, Maze Procedure, AF, Ablation
Location: Ann Arbor MI, Orlando FL, St. Helena CA
Sponsor: Pulse Biosciences, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06959121

Recruiting

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

for
Gastric Cancer, Gastroesophageal Junction Cancer
Location: Ann Arbor MI, Toronto, Skokie IL, Hershey PA,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06731478

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

for
Colorectal Adenomatous Polyp, Colorectal Carcinoma,
Location: Ann Arbor MI, Cleveland OH, Columbus OH
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05630794

Phase 1, Recruiting

Hemodynamics After Resistance Training

for
Perimenopause
Location: Ann Arbor MI
Sponsor: University of Michigan

Sex: Female

Age: 40 - 60

Code: NCT07022340

Recruiting

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

for
Prostate Cancer
Location: Ann Arbor MI, Madison WI, Durham NC, San Francisco CA
Sponsor: Duke University

Sex: Male

Age: 18+

Code: NCT07050433

Recruiting

Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation

for
Allogeneic Stem Cell Transplant
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT06784336

Phase 2, Recruiting

Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer

for
Urothelial Carcinoma
Location: Ann Arbor MI, Philadelphia PA
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT06356155

Phase 2, Recruiting

Training Community Members to be Coaches to Deliver the HealthyLifetime Program

for
Health Behaviors, Functional Decline, Chronic Disease,
Location: Ann Arbor MI
Sponsor: University of Michigan

Sex: All

Age: 30+

Code: NCT06616246

Recruiting

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

for
Barrett Esophagus,
Location: Ann Arbor MI, St Louis MO, Chapel Hill NC, Dallas TX
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06732388

Phase 2, Recruiting

Inorganic Nitrate (NaNO3) Prevention of Contrast-Associated Acute Kidney Injury

for
Kidney Injury, Acute
Location: Ann Arbor MI
Sponsor: University of Michigan

Sex: All

Age: 18+

Code: NCT07016074

Phase 2, Recruiting

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Ann Arbor MI, Columbus OH, Pittsburgh PA, Chicago IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT06900595

Phase 2, Recruiting

Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)

for
Familial Adenomatous Polyposis
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT06641310

Recruiting

Obeticholic Acid for Prevention in Barrett's Esophagus

for
Barrett Esophagus, Esophageal Adenocarcinoma
Location: Ann Arbor MI, Cleveland OH, St Louis MO, Chapel Hill NC,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04939051

Phase 2, Recruiting

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

for
Chemotherapy-Induced Peripheral Neuropathy,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT07365007

Recruiting

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Ann Arbor MI, Cleveland OH, London, Hamilton, Toronto,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07258511

Phase 3, Recruiting

A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial

for
Anatomic Stage 0 Breast Cancer AJCC v8,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 0+

Code: NCT07443943

Phase 2, Recruiting

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

for
Lung Cancer, Lung Metastases
Location: Ann Arbor MI, Philadelphia PA, Rochester MN, Orlando FL,
Sponsor: Vergent Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT07499674

Phase 3, Recruiting